Journal Report

CANCER LETTERS

Download PDF
Journal Information
Journal Title
CANCER LETTERS
Publisher
ELSEVIER IRELAND LTD
ISSN
0304-3835
E-ISSN
1872-7980
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Event-free survival in patients with early triple-negative breast cancer receiving platinum-free, de-escalated anti-PD-1 neoadjuvant therapy: an updated analysis of the NeoTENNIS trial
Shuang Hao, Xuliren Wang, Lin-Xiaoxi Ma et al.
2027-1 Vol. 664 Pages 218953
DOI: 10.1016/j.canlet.2026.218953
Atovaquone impedes muscle wasting in pancreatic cancer by AMPK modulation
Somsekhara Derangula, Pradip Kumar Jaiswara, Anupam Mandal et al.
2027-1 Vol. 664 Pages 218951
DOI: 10.1016/j.canlet.2026.218951
SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer
Shuwen Dong, Renhong Huang, Shaodong Wang et al.
2027-1 Vol. 664 Pages 218955
DOI: 10.1016/j.canlet.2026.218955
Comment on the Chinese guidelines for the diagnosis and treatment of pediatric craniopharyngioma (2025)
Ao Chen, Yiguang Chen, JianJian Zhang
2027-1 Vol. 664 Pages 218952
DOI: 10.1016/j.canlet.2026.218952
Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma
Xin Li, Yenan Wu, Minyi Lu et al.
2027-1 Vol. 664 Pages 218958
DOI: 10.1016/j.canlet.2026.218958
Saturation mutagenesis library screening identifies on-target secondary resistance mutations in KRASG12D-selective inhibitors
Hannan Xie, Gaoming Wang, Zhiqing Yuan et al.
2027-1 Vol. 664 Pages 218931
DOI: 10.1016/j.canlet.2026.218931
Reprogramming muscle proteostasis in cancer cachexia: Transcriptional mechanisms and therapeutic opportunities
Bowen Xu, Aishwarya Jaiswal, Silin Liu et al.
2027-1 Vol. 664 Pages 218944
DOI: 10.1016/j.canlet.2026.218944
Early WEE1 inhibition prevents senescence-like epigenetic reprogramming of pioneer TMZ-resistant cells and synergizes with temozolomide in MYC-high glioblastoma
Yilin Wu, Yuzhou Chang, Xiaoyang Qin et al.
2026-12 Vol. 662 Pages 218913
DOI: 10.1016/j.canlet.2026.218913
Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment
Weihua Wang, Songyue Guo, Qihui Chu et al.
2026-12 Vol. 662 Pages 218899
DOI: 10.1016/j.canlet.2026.218899
AMPK signaling in cancer: Molecular insights and therapeutic opportunities
Weiwei Jiang, Peiqiang Yan, Jingchao Wang et al.
2026-12 Vol. 662 Pages 218912
DOI: 10.1016/j.canlet.2026.218912
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 09:23